India Pharma Conference 2026 to spotlight innovation, global partnerships in New Delhi

Discussions are likely to centre on how the country can move up the pharmaceutical value chain

Glenmark gets USFDA approval for generic Endometrin vaginal inserts

Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million

OPPI and NIPER Raebareli partner to boost pharma research and talent

Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem

BOTOX Cosmetic launches programme to empower 250 women entrepreneurs

20 among them to receive $20,000 grants

HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care

The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment

Dr. Jitendra Singh urges industry to step up R&D collaboration

Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India

Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio

The acquisition complements Gilead’s existing oncology expertise and development infrastructure

Halozyme strikes global deal with Vertex to expand Hypercon drug delivery technology

The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets

RoosterBio taps MineBio to supercharge hMSC & exosome solutions in China

Stereotaxis bags FDA clearance for next-gen cath lab tech